Evidence map›Paper›PMID 42889153›Full record

ArticleFrontiers in public health2026

Paradoxical PM2.5-longevity estimates in global country panels are sensitive to differential trend control: a specification analysis, 2000-2023.

Hongzhi Lu, Hongxue Lu

Abstract read
In one paragraph

Article in Frontiers in public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hongzhi LuSchool of Industrial Technology, Universiti Sains Malaysia, Gelugor, Malaysia.
Hongxue LuFaculty of Education, University of Malaya, Kuala Lumpur, Malaysia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Country-year panels are widely used for environmental health research, but heterogeneous national trajectories can produce ecological coefficients that conflict with established health evidence. Methods: We assembled 4,406 country-year observations from 186 economies in the World Bank World Development Indicators for 2000-2023. Annual life expectancy was regressed on population-weighted ambient PM2.5 exposure using economy and year fixed effects, with adjustment for gross domestic product per capita, health expenditure, and urbanization. The original sensitivity analyses examined alternative weights, covariance estimators, exposure lags, sample restrictions, and temporal transformations; a future-exposure negative control tested residual temporal structure. Economy-specific trends and rolling five-year differences were added after the conventional estimate showed an unexpected positive sign. Results: The conventional adjusted model associated a 10 μg/m Conclusion: The positive conventional coefficient was not robust to trend-focused specifications, and the future-exposure pattern raised concern about unresolved temporal structure without constituting a stand-alone falsification test. The pattern is consistent with unresolved differential trajectories, but the analysis does not establish that trend heterogeneity is the sole source of bias. Aggregate PM2.5-longevity studies require explicit estimand definition, trend diagnostics, change-based estimators, covariance sensitivity checks, and temporal negative controls before interpreting coefficients as health effects.

Indexed as

Air PollutantsAir PollutionEnvironmental ExposureGlobal HealthLife ExpectancyLongevityParticulate MatterHumansAir PollutantsParticulate Matterambient air pollutiondifferential trendslife expectancynegative controlpanel dataPM2.5two-way fixed effects

Identifiers

PMID42889153
PMCPMC13669107

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.